The objective of this study was to improve the results of surgical treatment for patients with perforated gastroduodenal ulcers and peritonitis (PGDU-P) by applying the preperitoneal blockade.
Introduction
In the Russian Federation, the number of patients with complicated peptic ulcer disease (PUD) shows no tendency to decrease. The incidence of perforated gastroduodenal ulcers (PGDU) ranges from 4% to 30%, and the mortality rate is between 5% and 18%. [1] [2] [3] [4] [5] Annually, the number of patients who need surgical intervention for PUD complicated by perforation is about 7.5 to13 per 100,000 adult population. [1, 2, 6] Mortality in PUD patients in Russia is 30,000 or more people per year; the temporary disability after surgery is between 30 and 45 days. [1, 2] Despite the widespread adoption of minimally invasive technologies in the surgery of perforated peptic ulcer disease with peritonitis, laparotomy remains the most common prompt access. [1, 2, 6, 7] Laparotomy and surgical procedures in the abdomen are accompanied by traumatization of the abdominal muscles and peritoneum (the richly innervated tissues), which leads to a marked pain syndrome in the postoperative period. Pain triggers physiological responses that negatively affect the functioning of the organs and systems, with development of several pathophysiologic repercussions, such as prolonged paralytic ileus. [6] [7] [8] [9] [10] [11] [12] Traditional analgesia with the most commonly used opioid analgesics is often accompanied by side effects and worsens the postoperative period. [1, 2, 6, 10, 12] Currently, some authors consider catheterizing the surgical wound by infusing local anesthetics in the preperitoneal space as the most effective pain relief after laparotomy. [6, [8] [9] [10] [11] [12] [13] The foregoing indicates the need for further studies of the postoperative analgesia for patients with PGDU and peritonitis (PGDU-P) after laparotomy.
The main objective of our study was to improve the results of surgical treatment for patients with PGDU-P by applying the preperitoneal blockade.
Materials and Methods
The retrospective study was performed in the period from 2001 to 2015. The number of patients for primary selection was 190; the number of patients included in the subsequent analysis was 102.
One hundred and ninety patients with PGDU-P, aged from 18 to 74 years, underwent laparotomy, laparoscopic suturing of PGDU, and sanitation and drainage of the abdominal cavity in the surgical departments at the Ulyanovsk Regional Clinical Center of Specialized Types of Medical Aid in the period from 2001 to 2015.
Inclusion criteria were age 18 years and older, male and female, perforated pyloroduodenal peptic ulcer, laparotomy, PUD history up to 3 years, the reactive and toxic stage of peritonitis. Exclusion criteria were videolaparoscopy, perforated pyloroduodenal combined with concomitant ulcerogenic complications, toxic and terminal stage of peritonitis, cancer, myocardial infarction, and acute cerebrovascular accident.
This study included 102 patients (100/98% men and 2/2% women) with PGDU-P ( Table 1) . Patients between 18 and 30 years were predominant. All patients were admitted to hospital with duration of perforation between 12 and 16 hours before admission. Standard examination included general clinical, laboratory and special instrumental investigations (X-ray, endoscopy, ultrasound, video-endoscope, histological research methods). Pain was measured using the Visual Analog Scale (VAS) for Pain. The laboratory examination included the complete blood count, blood chemistry, urine diastase. Leukocyte intoxication index (LII) was calculated according to V. K. Ostrovsky (1983).
The measurements of intra-abdominal pressure (IAP) by indirect infravesical tensometry were performed daily from the first day after the operation. Measurements were performed in cm H 2 O and converted to mmHg (1 mmHg = 1.36 cmH2O).
Intra-abdominal hypertension (IAH) was identified at IAP greater than 12 mmHg. According to M. Sugrue and K. M. Hillman (1998), [14] IAH was identified at IAP greater than 12 mmHg.
Surgical interventions (laparotomy, laparoscopic suturing of PGDU, sanitation and drainage of the abdominal cavity) was performed under endotracheal anesthesia in all patients.
Patients were divided into two groups depending on the method of postoperative analgesia. Patients of Group 1 (n=62) were subjected only to systemic opioid analgesia (an intramuscular injection of 1% solution of Promedol 1ml 4 times a day). Patients of Group 2 were subjected to systemic opioid analgesia and catheterization of the preperitoneal space for infusion of 0.5% solution of Novocaine in the postoperative period.
The method was performed as follows: Before suturing of laparotomic wound, we formed tunnels in the preperitoneal space along the full length of the laparotomic wound left and right at a distance of 1.5-2.0 cm from its edges. In the left and right tunnels, plastic catheters with a few holes were inserted. The cannula (the external opening) of the catheter was fixed on the anterior abdominal wall. The catheters were fixed to the peritoneum using absorbable suture material. In the postoperative period, a 0.5% solution of Novocaine was injected through catheters for pain relief every 3 hours for 3 days (RF patent №2400259; a priority from 02.17.2009). [13] During the postoperative period, adequate fluid resuscitation was performed. Correction of water-salt balance was carried out under the control of the content of potassium, calcium, and sodium in the blood plasma. For parenteral nutrition, protein hydrolysates and glucose-insulin-potassium mixture were administered.
Nasogastric tube was left in place for at least 24 h after surgery. Prophylaxis and treatment of intestinal paresis was performed by administration of neostigmine methylsulfate (1ml of 0.05% solution subcutaneously 2 times a day) and hypertonic solution of sodium chloride (60-80 ml intravenously 1-2 times a day). In order to prevent septic complications, we administered intravenously third-generation cephalosporins.
The study was conducted in accordance with ethical principles of the Declaration of Helsinki. It was approved by the by Ethics Committee at the Ulyanovsk Regional Clinical Center of Specialized Types of Medical Aid. Written informed consent was obtained from all participants.
Statistical analysis was performed using the statistical software «Statistica». (v6.0, StatSoft, USA). Group comparisons with respect to categorical variables are performed using chi-square tests with the Yates' correction or, alternatively, Fisher's exact test when expected cell counts were less than 5. A probability value of P<0.05 was considered statistically significant.
Results
In assessing the effectiveness of preperitoneal blockade, a high degree of pain relief was found in the patients of Group 2 (3.3±0.4 points) (Tab. 2). Postoperative analgesia using preperitoneal blockade after laparotomy and suturing of perforated gastroduodenal ulcers reduced the pain intensity by 2 times in comparison with conventional analgesia.
IAH was detected in all patients in both groups starting from the third postoperative day. According to IAH severity, patients were distributed as follows: In Group 1, Grades I, II and III of IAH were determined in 18(29%), 36(58.1%), and 8(12.9%) of patients, respectively. In Group 2, IAH Grades I and II were detected in 28(70%) and 12(30%) of patients; we did not observed IAH Grade III in this Group (Tab. 3).
In patients with IAH Grades II and III (Group 1), the level of IAP decreased from 19.9±0.3 mmHg (the 3rd day) to 15.3±0.2 mmHg (the 6th day) and from 22.3±0.4 mmHg (the 3rd day) to 17.4±0.4 mmHg (the 7th day), respectively (p<0.05). In Group 2, we observed a significant decrease in the IAP level in patients with IAH Grades I and II from 14.8±0.2 mmHg (the 3rd day) to 12.1±0.3 mmHg (the 5th day) and from 19.4±0.3 mmHg (the 3rd day) to 15.1±0.2 mmHg (the 5th day), respectively (p<0.05). The preperitoneal blockade after laparotomy in PGDU-P patients reduced the IAP level by 2.7 mmHg at IAH Grade I and by 4.3 mmHg at Grade II for 2 days.
In Group 1, the first bowel movement (the first stool) we observed was at day 6.5±0.3, in Group 2 -at day 4.2±0.2. On the 2nd day of intervention, LII was 10.4±0.3CU in Group 1 (Table 4 ) and 8.1±0.2CU in Group 2 (p<0.05); at the 6th day, LII was also significantly lower in Group 2 than in Group 1; by the 10th day, LII was within normal range in all patients.
Thus, the superior efficiency of preperitoneal blockade was confirmed by significant differences between two Groups in the severity of intra-abdominal hypertension and time of data normalization.
The number of the early postoperative complications in Groups was as follows: gastrostasis was detected in 34(54.8%) patients in Group 1 and 16(40%) patients in Group 2; dynamic ileus in 25(40.3%) of patients in Group 1 and 12(30%) patients in Group 2; mechanical ileus (early adhesive disease of the abdominal cavity) in 1(1.6%) patient in Group 1 (relaparotomy was performed), this complication we did not observed in Group 2; pneumonia -in 10(16.1%) patients in Group 1 and 2(5%) patients in Group 2; seroma and suppuration of postoperative wound -in 14(22.6%) patients in Group 1 and 3(7.5%) patients in Group 2; thromboembolism and acute cardiovascular failure were identified only in one patient (1.6%) in Group 1 (Tab. 5).
The comparative evaluation of the incidence of the early postoperative complications showed that using preperitoneal blockade contributed to significantly reducing the complications in Group 2. Postoperative mortality was 1.6% in Group 1. Thromboembolism and acute cardiovascular failure was the cause of postoperative mortality in 1(1.6%) patients in Group 1. In Group 2, postoperative mortality was absent.
The duration of hospital treatment was 14.5±0.3 days in Group 1 and 11.2±0.2 days in Group 2 (P<0.05); the average length of stay was reduced by approximately 3 days compared to traditional anesthesia.
Discussion
Traditional laparotomy in patients with perforated gastroduodenal ulcers and peritonitis contributes to the longterm pain syndrome in the postoperative period, which disrupts the function of many organs and systems. [1, 2, 6, 10, 11] Pain that occurs after surgery has visceral and somatic components. [1, 2, 6, 10, 13] Somatic pain after laparotomy is determined by the direct traumatization of tissue during surgical access. It is known that chronic stimulation of spinal afferents from visceral organs may elicit pain, hyperalgesia and allodynia in the referred zones of the deep somatic tissues (skin, subcutaneous tissue, muscles and fascia). [15] Reduced visceral pain signaling within the spinal cord has been shown to reciprocally diminish cutaneous sensitization. [16] Nociceptive pain is caused by irritation of nociceptors in the parietal peritoneum. [1, 2, 6, 10, 13] T. Brennan et al. showed [17] that the blockade of parietal afferents may reduce spinal dorsal horn neuron sensitization thereby providing postoperative analgesia that outlasts the duration of wound infusion. Furthermore, animal studies have shown that parietal pain may sensitize neurons in the spinal cord to visceral colonic pain. [18] [19] This sensitization most likely reflects convergence of afferent information from the gut and somatic system within the spinal cord (heterosynaptic facilitation). [20] Thus, the peritoneum and the deep muscular layer play a crucial role in the pain induced by abdominal incisions. This assumption is further supported by the failure of epidural analgesia when metameric level is not high enough to block peritoneal nociceptive influx, even after lower abdominal surgery. [21] Therefore, it cannot be excluded that blockade of parietal pain influx may even contribute to a reduction of the visceral component of pain. [22] The preperitoneal infusion of ropivacaine has recently been shown to prevent mechanical and visceral sensitivity following laparotomy in an animal model. High-dose ropivacaine administered via a preperitoneal infusion or systemic boluses had the same effect on mechanical and visceral sensitivity after laparotomy. [23] According to Beaussier M et al., [22] preperitoneal continuous infiltration of 0.2% ropivacaine at 10 ml/h during 48 h was an effective method to relieve pain after open colorectal surgery. It reduced morphine consumption and accelerated the postoperative recovery.
Time to ileus resolution after abdominal surgery is one of the most important factors contributing to the duration of hospital stay. A number of pathogenic mechanisms have been proposed for postoperative Ileus. [24] [25] Earlier resolution of postoperative ileus has been reported in studies of continuous local anaesthetic wound infusion. [22, 26, 27] Our results show that the introduction of 0.5% solution of Novocaine in the preperitoneal space after laparotomy in PGDU-P patients promotes blocking the parietal and tissue pain receptors, which ensures a high degree of pain relief. We believe that the significant decrease in the number of such early postoperative complications as a dynamic ileus and wound inflamations is associated with adequate anesthesia during preperitoneal blockade. In agreement with other reports on continuous local anesthetic wound perfusion, no local complications were observed. [22, 28] 
Conclusion
Postoperative analgesia using preperitoneal blockade after laparotomy and suturing of perforated gastroduodenal ulcers reduced the pain intensity by 2 times in comparison with conventional analgesia. The preperitoneal blockade after laparotomy in PGDU-P patients promotes the effective reduction of IAH for 2 days.
